Case 2:22-cv-01754-MEF-JBC Document 27 Filed 05/24/22 Page 1 of 3 PagelD: 653
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`LA JOLLA PHARMACEUTICAL
`COMPANY; LA JOLLA PHARMA, LLC
`and THE GEORGE WASHINGTON
`UNIVERSITY,
`
`Civil Action No. 2:22-cv-01754 (JXN)(JBC)
`Plaintiffs,
`Filed Electronically
`V.
`
`GLAND PHARMA LIMITED, SHANGHAI
`FOSUN PHARMACEUTICAL (GROUP)
`CO., LTD. and FOSUN PHARMA USA INC.
`
`Defendants.
`
`STIPULATION OF DISMISSAL WITHOUT PREJUDICE AS TO DEFENDANTS
`SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
`AND FOSUN PHARMA USA INC.
`
`Plaintiffs La Jolla Pharmaceutical Company, La Jolla Pharma, LLC, and The George
`Washington University (collectively, “Plaintiffs”) and Defendants Gland Pharma Limited
`(“Gland”), Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Shanghai”) and Fosun
`Pharma USA Inc. (“Fosun USA”) (collectively, “Defendants”) hereby stipulate as follows:
`
`1. The Complaint (ECF No. 1) against Fosun Shanghai and Fosun USA shall be
`dismissed without prejudice pursuant to Fed. R. Civ. P. 41(a)(1)(A) (i) and (i1).
`
`2. This action will continue against Gland.
`
`3. Nothing in this stipulation shall in any way limit Plaintiffs’ right to move to
`amend the pleadings on or before the deadline set by the Court. Likewise, nothing in this
`stipulation shall constitute a waiver by Gland, Fosun Shanghai, or Fosun USA of any objection
`
`or defense to any motion to amend the pleadings.
`
`
`
`
`
`
`
`
`Case 2:22-cv-01754-MEF-JBC Document 27 Filed 05/24/22 Page 2 of 3 PagelD: 654
`
`4. Nothing in this stipulation shall constitute a waiver of any discovery available to
`
`Plaintiffs under the Federal Rules of Civil Procedure, the Federal Rules of Evidence, or any other
`
`applicable authority, including without limitation, discovery relating to Gland’s marketing
`
`partner(s) for Gland’s ANDA. Likewise, nothing in this stipulation shall constitute a waiver by
`
`Gland of any objection or defense to, or any privilege or immunity from, any discovery sought
`
`by Plaintiffs.
`
`5. The case caption should be amended to read: “La Jolla Pharmaceutical Company,
`
`La Jolla Pharma, LLC, and The George Washington University v. Gland Pharma Limited, Civil
`
`Action No. 2:22-cv-01754 (JXN)(JBC)”.
`
`6. Each party shall bear its own fees, expenses, and costs.
`
`s/ Charles H. Chevalier
`
`Charles H. Chevalier
`GIBBONS P.C.
`One Gateway Center
`
`Newark, New Jersey 07102-5310
`
`(973) 596-4500
`
`cchevalier@gibbonslaw.com
`Of Counsel:
`
`Edgar H. Haug
`
`Sandra Kuzmich, PhD
`Nicholas F. Giove
`
`Andrew S. Wasson
`
`Anna N. Lukacher
`
`HAUG PARTNERS LLP
`
`745 Fifth Avenue
`
`New York, NY 10151
`ehaug@haugpartners.com
`skuzmich@haugpartners.com
`ngiove@haugpartners.com
`awasson@haugpartners.com
`alukacher@haugpartners.com
`
`s/ Justin T. Quinn
`
`Justin T. Quinn
`
`ROBINSON MILLER LLC
`Ironside Newark
`
`110 Edison Place, Suite 302
`Newark, NJ 07102
`
`(973) 690-5400
`JQuinn@rwmlegal.com
`
`Imron T. Aly (pro hac vice forthcoming)
`ARENTFOX SCHIFF LLP
`
`233 S. Wacker Dr., Suite 6600
`
`Chicago, IL 60606
`
`(312) 258-5500
`
`imron.aly@afslaw.com
`
`Ahmed M.T. Riaz (pro hac vice forthcoming)
`ARENTFOX SCHIFF LLP
`
`1185 Avenue of the Americas, Suite 3000
`New York, NY 10036
`
`(212) 753-5000
`
`ahmed.riaz@afslaw.com
`
`Attorneys for Defendant Gland Pharma Limited
`
`
`
`
`
`
`
`
`Case 2:22-cv-01754-MEF-JBC Document 27 Filed 05/24/22 Page 3 of 3 PagelD: 655
`
`Attorneys for Plaintiffs La Jolla
`Pharmaceutical Company, La Jolla Pharma,
`
`LLC, and The George Washington University
`
`IT IS SO ORDERED this 24th day of May, 2022.
`
`HON E JULIEN XAVIER NEALS
`Unifed Stgges Districtf Judge
`
`
`
`
`
`
`
`
`
`